Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Endo International stock

Learn how to easily invest in Endo International stock.

Endo International plc is a drug manufacturers-specialty & generic business based in the US. Endo International shares (ENDP) are listed on the NASDAQ and all prices are listed in US Dollars. Endo International employs 3,397 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Endo International

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ENDP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Endo International stock price (NASDAQ: ENDP)

Use our graph to track the performance of ENDP stocks over time.

Endo International shares at a glance

Information last updated 2022-01-17.
Latest market close$3.21
52-week range$1.94 - $10.89
50-day moving average $4.91
200-day moving average $4.63
Wall St. target price$6.40
PE ratio 11.1986
Dividend yield N/A (0%)
Earnings per share (TTM) $0.29

Buy Endo International shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Endo International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Endo International price performance over time

Historical closes compared with the close of $3.21 from 2022-01-21

1 week (2022-01-14) -1.83%
1 month (2021-12-23) -24.47%
3 months (2021-10-22) -29.61%
6 months (2021-07-23) -35.80%
1 year (2021-01-22) -53.68%
2 years (2020-01-24) -45.78%
3 years (2019-01-24) 9.52
5 years (2017-01-24) 11.85

Is Endo International stock undervalued or overvalued?

Valuing Endo International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Endo International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Endo International's P/E ratio

Endo International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Endo International shares trade at around 11x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Endo International's EBITDA

Endo International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $560.1 million.

The EBITDA is a measure of a Endo International's overall financial performance and is widely used to measure a its profitability.

Endo International financials

Revenue TTM $3 billion
Operating margin TTM 26.55%
Gross profit TTM $1.5 billion
Return on assets TTM 5.34%
Return on equity TTM 0%
Profit margin 2.3%
Book value $-2.61
Market capitalisation $764.1 million

TTM: trailing 12 months

Endo International share dividends

We're not expecting Endo International to pay a dividend over the next 12 months.

Endo International share price volatility

Over the last 12 months, Endo International's shares have ranged in value from as little as $1.94 up to $10.89. A popular way to gauge a stock's volatility is its "beta".

ENDP.US volatility(beta: 1.1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Endo International's is 1.0973. This would suggest that Endo International's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Endo International overview

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

Frequently asked questions

What percentage of Endo International is owned by insiders or institutions?
Currently 1.597% of Endo International shares are held by insiders and 76.18% by institutions.
How many people work for Endo International?
Latest data suggests 3,397 work at Endo International.
When does the fiscal year end for Endo International?
Endo International's fiscal year ends in December.
Where is Endo International based?
Endo International's address is: Minerva House, Dublin, Ireland, 4
What is Endo International's ISIN number?
Endo International's international securities identification number is: IE00BJ3V9050
What is Endo International's CUSIP number?
Endo International's Committee on Uniform Securities Identification Procedures number is: 29264F205

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site